Associated Papers
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
Sakamoto Y et al.
Hematological Oncology, 2022
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Sakamoto Y et al.
British Journal of Haematology, 2021
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma.
Fujii K et al.
The Journal of Pathology. Clinical Research, 2021
cDNA-Based Mutation Screening Using a Combination of High-Resolution Melting Curve and Fragment Analysis Facilitates Efficient CCR4 Mutation Analysis in Adult T-Cell Leukemia/Lymphoma.
Mizuta S et al.
American Journal of Clinical Pathology, 2020
CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma.
Sakamoto Y et al.
International Journal of Hematology, 2019
Select a paper to view details